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Pulmonary toxoplasmosis is a challenging diagnosis in immunosuppressed patients with nonspecific clinical picture and ra-
diologic findings. We present a case of pneumonia due to Toxoplasma gondii diagnosed by polymerase chain reaction 
(PCR) in the bronchoalveolar lavage (BAL) fluid of a patient with acquired immunodeficiency syndrome (AIDS). Coinfection 
with Pneumocystis jirovecii was found in the same specimen. Direct examination and culture for bacteria, mycobacteria and 
other fungus were negative. Despite the intensive management, respiratory compromise evolved rapidly, with the need for 
ventilatory support. Acute respiratory distress syndrome developed, and the patient died of multiple organ failure. This case 
illustrates that a high index of suspicion is necessary for diagnosis of pulmonary toxoplasmosis, a potentially fatal condition. 
Due to high diagnostic performance, PCR in BAL fluid should be included in the evaluation of immunosuppressed patients 
with nonspecific pulmonary diseases.  




O diagnóstico de toxoplasmose pulmonar em pacientes imunossuprimidos é difícil, devido ao quadro clínico e aos achados 
radiológicos inespecíficos. Neste artigo, relatamos o caso de uma paciente com síndrome da imunodeficiência adquirida 
(SIDA), que apresentou pneumonia por Toxoplasma gondii diagnosticada através de reação em cadeia da polimerase (P-
CR) no lavado bronco-alveolar (LBA). A paciente apresentava co-infecção com Pneumocystis jirovecii. Os demais exames 
microbiológicos, como bacterioscópico, cultural para bactérias, micobactérias e fungos, foram negativos. Apesar do manejo 
intensivo, a paciente evoluiu com síndrome do desconforto respiratório agudo e óbito por falência múltipla dos órgãos. Este 
caso demonstra que um alto índice de suspeita clínica é necessário para o diagnóstico de pneumonia por Toxoplasma gon-
dii. Devido ao seu desempenho diagnóstico, o PCR para Toxoplasma gondii no LBA deve ser incluído na avaliação de paci-
entes imunossuprimidos com quadros pulmonares inespecíficos. 
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Pneumonia due to Toxoplasma gondii is an 
uncommon and underdiagnosed condition. It is 
usually a result of reactivation of a latent chronic 
infection (1). Immunosuppressed patients are 
particularly susceptible to the disseminated dis-
ease (2). Most cases occur in patients who have 
undergone bone marrow (3) or heart transplanta-
tion, and less often, in those with acquired im-
munodeficiency syndrome (AIDS) (4-6). Pulmo-
nary toxoplasmosis can present as isolated 
pneumonitis or as part of a disseminated dis-
ease. It is difficult to diagnose and is frequently 
discovered only at autopsy (4,7). Screening for 
the infection can be done by serology, but this 
strategy lacks specificity. The radiographic pat-
terns of toxoplasmosis are nonspecific (1). Lung 
biopsy or fiber-optic bronchoscopy (FOB) with 
bronchoalveolar lavage (BAL) are essential, 
since direct identification of the organism is the 
gold standard for diagnosis. The amplification of 
the T. gondii DNA by polymerase chain reaction 
(PCR) is a promising technique for diagnosis. 
PCR was shown to be sensitive and highly spe-
cific for detecting toxoplasmic disease (8-10). 
We report a case of disseminated toxoplasmosis 




A 63-year-old, white, female patient was re-
ferred to a tertiary hospital because of a 2-week 
history of dry cough and fever. Her medical re-
cords disclosed a history of an infiltrating ductal 
carcinoma of the breast, stage IIIA (pT2pN2M0), 
resected 7 months earlier and treated with three 
cycles of adjuvant chemotherapy with cyclo-
phosphamide, doxorubicin and fluorouracil 
(CAF). After the third cycle, 2 months earlier, she 
developed febrile neutropenia, which resolved 
after treatment with cefepime. Despite resolution 
of fever, incomplete hematological recovery was 
observed (persistent leukopenia), and chemo-
therapy was withheld. On admission, the patient 
was febrile, in breathing distress and oral thrush 
was noted. She had pancytopenia, hypoxemia 
with an elevated alveolar-arterial gradient and 
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lactate dehydrogenase (LDH) of 1,590 mg/dL. 
Thoracic radiograph showed bilateral diffuse 
infiltrates. Antibiotics for coverage of community 
acquired pneumonia and Pneumocystis jirovecii 
infection were started. The patient developed 
mental confusion and underwent brain computed 
tomography (CT) that showed a left frontal hy-
podensity with discrete contrast impregnation 
and another hypodensity on the right thalamic 
region that did not enhanced on contrast imag-
ing. Lumbar puncture showed the following re-
sults: opening pressure = 180 cmH2O, leuco-
cytes = 1/mm
3
, protein = 30 mg/dL, glucose = 40 
mg/dL (serum = 74 mg/dL), adenosine deami-
nase (ADA) = 3 U/L. Non-reactants venereal 
disease research laboratory (VDRL) and fluores-
cent treponemal antibody absorbed (IFI-FTABs) 
tests, direct examination and culture for bacteria, 
fungus and mycobacteria where negative. PCR 
for mycobacteria, toxoplasmosis, herpes zoster 
(HZV) and John Cunningham (JC) viruses were 
also negative. An ELISA anti-HIV test was posi-
tive. Serology for T. gondii was positive for im-
munoglobulin G (IgG) and negative for immu-
noglobulin M (IgM). A presumptive diagnosis of 
toxoplasmic encephalitis was made, and clinda-
mycin, pyrimethamine and folinic acid were 
added to sulfamethoxazole-trimethoprim (SMT-
TMP). A fiber-optic bronchoscopic BAL was per-
formed. Direct examination for Pneumocystis 
jirovecii and PCR for Pneumocystis jirovecii and 
T. gondii were positive. Direct examination and 
culture for bacteria, mycobacteria and other fun-
gus were negative. Despite the intensive man-
agement, respiratory compromise evolved rap-
idly, with the need for ventilatory support. Acute 
respiratory distress syndrome developed, and 




Most patients with pulmonary toxoplasmo-
sis present with dry cough, dyspnea, and fever 
(1). Due to the infrequency of this clinical entity, 
diagnosis of pulmonary toxoplasmosis can be 
easily overlooked. Clinical and radiologic find-
ings are nonspecific and cannot be distinguished 
from other more common opportunistic infections 
(6). In spite of morbidity, thoracoscopic or open 
lung biopsy remain the gold standards for diag-
nosis. Direct visualization of tachyzoites on 
Giemsa staining has low sensitivity and depends 
on the pathologists’ skills. In this context, less 
invasive and more reliable diagnostic techniques 
are necessary. Although rarely requested in 
BAL, PCR for T. gondii can be a fast and effec-
tive diagnostic tool (8-14). A correct diagnosis 
made in a timely fashion, followed by the ad-
ministration of pyrimethamine and sulfonamides, 
assures an excellent survival rate for immuno-
competent patients and a 60% survival rate for 
immunosuppressed patients (1,6). 
In the case reported, pulmonary toxoplas-
mosis was diagnosed by a positive PCR in BAL. 
The lung is the second most common organ af-
fected in extracerebral toxoplasmosis (4,7). Pre-
vious studies of AIDS patients who underwent 
FOB with BAL found 2-14% of T. gondii PCR 
positivity (9,10,12,13). Despite reports of isolated 
extracerebral toxoplasmosis in AIDS patients, 
the most common form of the disease is with 
central nervous system involvement (7). Our 
patient’s brain CT showed a highly suggestive 
pattern for neurotoxoplasmosis. However, a 
negative PCR for T. gondii was found on the 
cerebrospinal fluid (CSF). This could be ex-
plained by previous administration of SMT-TMP. 
Foudrinier et al. found a substantial reduction of 
T. gondii CSF PCR sensitivity, from 60 to 16%, 
in patients under anti-toxoplasmic treatment or 
P. jirovecii prophylaxis (14).  
In immunosuppressed AIDS patients, con-
comitant opportunistic infections are not un-
common. Cases of pulmonary coinfection of 
Pneumocystis jirovecii and T. gondii have been 
previously reported (15-17). In this case, clinical 
deterioration with acute respiratory distress syn-
drome and multiple organ dysfunction syndrome 
could be explained by either infection (18).  
This case illustrates that a high index of 
suspicion is necessary for diagnosis of pulmo-
nary toxoplasmosis, a potentially fatal condition. 
Due to high diagnostic performance, PCR in BAL 
should be included in the evaluation of immuno-
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